Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Among IVF Patients Undergoing Fixed Antagonist Protocols With Recombinant FSH, Does Administration of Recombinant FSH From Cycle Day 5 Onwards Compared With Cycle Day 2 Onwards, Yield a Higher Number of Good Quality Embryos?

NCT00823472 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00823472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00823472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Among IVF Patients Undergoing Fixed Antagonist Protocols With Recombinant FSH, Does Administration of Recombinant FSH From Cycle Day 5 Onwards Compared With Cycle Day 2 Onwards, Yield a Higher Number of Good Quality Embryos?
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2009
Completion date
October 31, 2010
Enrollment
147 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

in vitro fertilization, ovulation induction